Octanate (human Factor VIII/von Willebrand Factor) / Octapharma  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Octanate (human Factor VIII/von Willebrand Factor) / Octapharma
RESIST NAIVE, NCT01051544 / 2008-007016-15: Study of First TIME Immunotolerance Induction in Severe Hemophilia A Patients With Inhibitor at High Risk of Failure: Comparison With FVIII Concentrates With or Without Von Willebrand Factor - RES.I.S.T. Naive

Withdrawn
N/A
0
NA
FVIII Concentrates, Including but not limited to:, Advate, Beriate P, Hemofil M, Helixate, Kogenate, Kogenate SF, Monarch M, Monoclate, Recombinate, Refacto, Replenate, Xyntha, FVIII/VWF concentrates, Koate-DVI, 8Y, Optivate, Alphanate, Fahndi, Haemate P, Humate P, Haemoctine SDH, Octanate, Wilate, Emoclot DI, Factane
City of Hope Medical Center, Charta Foundation, Grifols Biologicals, LLC, CSL Behring, Biotest Pharmaceuticals Corporation, Grifols Therapeutics LLC
Severe Hemophilia A
06/20
06/20
RESIST EXP, NCT01051076 / 2008-007019-33: Rescue Immunotolerance Study in Induction of Immune Tolerance (ITI)-Experienced Patients (RES.I.S.T. Experienced)

Completed
N/A
3
US
VWF/FVIII concentrates, Koate-DVI, Emoclot DI, Factane, 8Y, Optivate, Alphanate, Fahndi, Haemate P, Humate P, Haemoctine SDH, Octanate, Wilate
City of Hope Medical Center, Charta Foundation, Grifols Biologicals, LLC, CSL Behring, Biotest Pharmaceuticals Corporation, Grifols Therapeutics LLC
Severe Hemophilia A
10/20
10/20
MOTIVATE, NCT04023019: Treatment of Hemophilia A Patients With FVIII Inhibitors

Recruiting
N/A
120
Europe, US
Nuwiq, Octanate, Wilate, Emicizumab, Hemlibra, Recombinant factor VIIa (rFVIIa), NovoSeven, Activated prothrombin complex concentrate (aPCC), FEIBA
Emory University, Octapharma
Hemophilia A
12/28
06/29
Protect-NOW, NCT03695978: Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients

Recruiting
N/A
200
Europe, Canada, US, RoW
Octapharma
Haemophilia A
06/30
06/30

Download Options